As per the report titled ‘Africa Molecular Diagnostics Market Size By Technology, Application, Industry Analysis Report, Country Outlook, Application Potential, Competitive Market Share & Forecast, 2020 - 2026’, available with Market Study Report, Africa molecular diagnostics market is projected to accrue USD 839 million by the end of the forecast duration.
 

According to the findings of the report, rising prevalence of communicable diseases like rotavirus diseases, tuberculosis, chronic obstructive pulmonary disease (COPD), and HIV/AIDS serve as major growth impetus for Africa molecular diagnostics market growth.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3001268/
 

Moreover, expanding geriatric populace who are at a higher risk of acquiring various diseases, incremental innovations and advancement in molecular diagnostics, and increasing initiatives by government and industry players are other rationales contributing to the industry expansion in Africa. In addition, rising focus towards reducing time-consumption in testing and avoiding contamination amid the Covid-19 pandemic has bolstered the demand for molecular diagnostics in the region.
 

Based on technology, Africa molecular diagnostics industry is fragmented into PCR, chips and microarrays, sequencing, in-situ hybridization, mass spectrometry, isothermal amplification, and others. Trusted projections cite that PCR segment is estimated to register 12.5% CAGR through 2026, as this technology enables rapid identification of pathogen. Moreover, adoption of real-time PCR (RT-PCR) that offers more accurate and faster processing for generating qualitative and quantitative results, increasing cases of genetic disorders and infectious ailments, along with inflowing public & private investment in R&D will significantly boost the segmental share in the coming years.
 

Speaking of the application spectrum, Africa molecular diagnostics market is divided into blood screening, infectious disease, genetic testing, and oncology testing. Genetic testing segment was worth USD 23 million in 2019, attributable to its wide application area and technological advancements in this field. Application in pre-symptomatic & predictive testing, newborn screening, and pharmacogenetics testing are likely to propel the demand genetic testing in the coming years. Moreover, growing demand for the technology from genetic specialists as well as primary care physicians will enhance the segment growth.
 

On the geographical front, Nigeria molecular diagnostics market held USD 23 million in 2019 and is expected to gain considerable traction over the forecast timeline. Rising number of initiatives by both government and non-government firms to promote awareness about diseases such as tuberculosis and HIV for effective patient care is driving the industry growth in Nigeria. For instance, AIDS Prevention Initiative in Nigeria (APIN) is a donation-funded non-government organization whose sole goal is to ensure effective treatment and prevention of infectious diseases like HIV and STDs.
 

Key players influencing Africa molecular diagnostics industry are Thermo Fisher Scientific, Inc., Sysmex Corp., Siemens Healthineers AG, Qiagen N.V., Myriad Genetics, Inc., Johnson & Johnson Services, Inc., Hologic Inc. (Gen Probe), F. Hoffmann-La Roche Ltd., and Danaher Corp., among others.